Compare
Mitesco, Inc. vs Bioregenx, Inc. vs Real Messenger Corp vs Bubblr Inc.
| Latest fiscal year | Mitesco, Inc. MITIRevenue covers only part of its income (partial revenue) | Bioregenx, Inc. BRGX | Real Messenger Corp RMSG | Bubblr Inc. BBLR |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2026-03-31 | 2025-12-31 |
| Revenue | n/a | $1.85M | $29.5K | $3.4K |
| Revenue growth (YoY) | n/a | -20.8% | n/a | -37.0% |
| Gross margin | n/a | 81.1% | 51.5% | 91.7% |
| Operating margin | n/a | -67.1% | n/m | n/m |
| Net margin | n/a | -83.2% | n/m | n/m |
| Net income | $498.7K | -$1.54M | -$4.09M | -$1.27M |
| EPS (Diluted) | -$0.14 | $0.00 | -$0.44 | -$0.01 |
| Operating cash flow | -$701.6K | $39.0K | -$3.57M | -$271.0K |
| Free cash flow | n/a | $29.9K | -$3.58M | n/a |
| Cash & equivalents | $100.9K | n/a | $322.0K | n/a |
| Total assets | $132.1K | $411.0K | $995.4K | $1.28M |
| Total liabilities | $23.60M | $4.95M | $508.5K | $4.17M |
| Shareholders' equity | -$23.47M | -$4.54M | $486.8K | -$2.89M |
| Return on year-end equity | n/a | n/a | -840.6% | n/a |
| Shares outstanding | 15.09M | 969.02M | n/a | 177.59M |
Revenue, most recent five fiscal years
| Fiscal year | Mitesco, Inc. | Bioregenx, Inc. | Real Messenger Corp | Bubblr Inc. |
|---|---|---|---|---|
| Latest | n/a | $1.85M Ended 2025-12-31 | $29.5K Ended 2026-03-31 | $3.4K Ended 2025-12-31 |
| 1 year earlier | n/a | $2.34M Ended 2024-12-31 | n/a | $5.3K Ended 2024-12-31 |
| 2 years earlier | n/a | $3.41M Ended 2023-12-31 | n/a | $2.6K Ended 2023-12-31 |
| 3 years earlier | n/a | $42.2K Ended 2022-12-31 | n/a | n/a |
| 4 years earlier | n/a | $198.6K Ended 2021-12-31 | n/a | n/a |